New Approach to Postsurgical Care Reduces Patient Recovery Time After Liver Resection

Patients undergoing oncologic liver surgeries who participated in an enhanced recovery program returned sooner to their normal life function and to adjuvant cancer therapies than patients who were treated with a traditional approach to perioperative care. These findings were published in the Journal of the American College of Surgeons (2015; doi:10.1016/j.jamcollsurg.2015.09.011).

"What really matters is life function. Until now, we have been trying to add up a patient's pain, nausea, and fatigue, but what we really needed to look at is how those symptoms actually impact a patient's life function, because as it turns out, each patient experiences symptoms differently," said lead investigator Thomas A. Aloia, MD, FACS, associate professor, department of surgical oncology, The University of Texas MD Anderson Cancer Center, Houston.

"We found that you could have very symptomatic people who were quite functional, and you could have mildly symptomatic people who were completely disabled."

This single-center study involved 118 patients undergoing both open and laparoscopic hepatectomy. In addition to traditional quality metrics such as complications and length of stay, researchers collected data from the MD Anderson Symptom Inventory (MDASI), a patient-reported outcomes tool. All patients rated symptom severity and life interference using this validated survey, first preoperatively and again at every outpatient visit until 31 days after their procedures.

Typically, surgeons counsel patients that they are not going to feel better for a month after the operation, and that their full recovery will take approximately 6 to 8 weeks. "Enhanced recovery," however, is a multicomponent perioperative care protocol created to speed patients' recovery and return to normal life functions such as working and driving.

This type of fast-track care plan involves preoperative patient education, fewer narcotic painkillers used during and after surgery (which have side effects that can lengthen the hospital stay), and a quicker return to eating and walking as soon as possible after the procedure.

In this study, 75 patients in the enhanced recovery group were compared with 43 patients in the traditional care group. All preoperative and postoperative care was the same for both groups, except the enhanced recovery part of it. The aim was to compare the difference between patients' functional outcomes.

The researchers found that patients treated in the enhanced recovery group were 2.6 times more likely to achieve their baseline functional status within 31 days than those who were treated with the traditional protocol.

"The only independent factor that correlated to faster return to baseline functional status, both in terms of absolute value and short time to recovery, was being on an enhanced recovery protocol," Aloia said. "It wasn't the size of the liver resection, the approach [laparoscopic versus open operation], or whether we used an epidural catheter for pain control or not."

In this study, enhanced recovery patients reported lower postoperative pain scores and experienced fewer complications and decreased length of stay. The breakthrough from this study is that most enhanced recovery studies stop measuring their outcome at length of hospital stay, with the sole purpose of shortening the hospital visit.

"At a cancer center, length of stay is pretty low on our list of importance; our true metric of success is getting people after cancer surgery back to cancer therapy," Aloia said.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs